These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 15561279)

  • 21. Preoperative administration of FTY720 prolonged renal allograft survival.
    Ueda H; Takahara S; Itoh S; Nomi H; Shibahara N; Katsuoka Y
    Transpl Immunol; 2005 Mar; 14(1):1-8. PubMed ID: 15814275
    [TBL] [Abstract][Full Text] [Related]  

  • 22. FTY720 mediates cytochrome c release from mitochondria during rat thymocyte apoptosis.
    Matsumura M; Tsuchida M; Isoyama N; Takai K; Matsuyama H
    Transpl Immunol; 2010 Aug; 23(4):174-9. PubMed ID: 20600904
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The S1P receptor modulator FTY720 prevents the development of experimental colitis in mice.
    Deguchi Y; Andoh A; Yagi Y; Bamba S; Inatomi O; Tsujikawa T; Fujiyama Y
    Oncol Rep; 2006 Oct; 16(4):699-703. PubMed ID: 16969482
    [TBL] [Abstract][Full Text] [Related]  

  • 24. FTY720 inhibits TH1-mediated allogeneic humoral immune response.
    Peñuelas-Rivas G; Domínguez-Perles R; Brinkmann V; Del Rio ML; Muñoz-Luna A; Ramírez-Romero P; Parrilla-Paricio P; Rodríguez-Barbosa JI
    Transplant Proc; 2005 Nov; 37(9):4124-6. PubMed ID: 16386642
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sphingosine 1-phosphate receptor agonism impairs skin dendritic cell migration and homing to secondary lymphoid tissue: association with prolonged allograft survival.
    Lan YY; Tokita D; Wang Z; Wang HC; Zhan J; Brinkmann V; Thomson AW
    Transpl Immunol; 2008 Nov; 20(1-2):88-94. PubMed ID: 18694829
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Leishmania (Leishmania) amazonensis infection in mice treated with FTY720.
    Lopes CT; de Paula DM; Cury PM; Valero-Lapchik VB; Bueno V
    Transplant Proc; 2010 Mar; 42(2):578-81. PubMed ID: 20304196
    [TBL] [Abstract][Full Text] [Related]  

  • 27. FTY720 exerts a survival advantage through the prevention of end-stage glomerular inflammation in lupus-prone BXSB mice.
    Ando S; Amano H; Amano E; Minowa K; Watanabe T; Nakano S; Nakiri Y; Morimoto S; Tokano Y; Lin Q; Hou R; Ohtsuji M; Tsurui H; Hirose S; Takasaki Y
    Biochem Biophys Res Commun; 2010 Apr; 394(3):804-10. PubMed ID: 20233577
    [TBL] [Abstract][Full Text] [Related]  

  • 28. FTY720 in combination with cyclosporine--an analysis of skin allograft survival and renal function.
    Silva FR; Silva LB; Cury PM; Burdmann EA; Bueno V
    Int Immunopharmacol; 2006 Dec; 6(13-14):1911-8. PubMed ID: 17161344
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of FK506 on rat thymic epithelial cells; immunohistochemical study.
    Takai K; Tokuda N; Sawada T; Fujikura Y; Jojima K; Sakatoku J; Fukumoto T
    Thymus; 1992 Jun; 19(4):207-17. PubMed ID: 1378235
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The in vivo induction of lymphocyte apoptosis in MRL-lpr/lpr mice treated with FTY720.
    Suzuki S; Li XK; Shinomiya T; Enosawa S; Amemiya H; Amari M; Naoe S
    Clin Exp Immunol; 1997 Jan; 107(1):103-11. PubMed ID: 9010264
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Physiologically based pharmacokinetic modeling of FTY720 (2-amino-2[2-(-4-octylphenyl)ethyl]propane-1,3-diol hydrochloride) in rats after oral and intravenous doses.
    Meno-Tetang GM; Li H; Mis S; Pyszczynski N; Heining P; Lowe P; Jusko WJ
    Drug Metab Dispos; 2006 Sep; 34(9):1480-7. PubMed ID: 16751263
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunosuppressant FTY720 inhibits thymocyte emigration.
    Yagi H; Kamba R; Chiba K; Soga H; Yaguchi K; Nakamura M; Itoh T
    Eur J Immunol; 2000 May; 30(5):1435-44. PubMed ID: 10820391
    [TBL] [Abstract][Full Text] [Related]  

  • 33. FTY720 suppresses the development of colitis in lymphoid-null mice by modulating the trafficking of colitogenic CD4+ T cells in bone marrow.
    Fujii T; Tomita T; Kanai T; Nemoto Y; Totsuka T; Sakamoto N; Nakamura T; Tsuchiya K; Okamoto R; Watanabe M
    Eur J Immunol; 2008 Dec; 38(12):3290-303. PubMed ID: 19009523
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of FTY720, a novel immunosuppressant, on experimental autoimmune uveoretinitis in rats.
    Kurose S; Ikeda E; Tokiwa M; Hikita N; Mochizuki M
    Exp Eye Res; 2000 Jan; 70(1):7-15. PubMed ID: 10644416
    [TBL] [Abstract][Full Text] [Related]  

  • 35. FTY720 attenuates lesional interleukin-17(+) cell accumulation in rat experimental autoimmune neuritis.
    Zhang ZY; Zhang Z; Schluesener HJ
    Neuropathol Appl Neurobiol; 2009 Oct; 35(5):487-95. PubMed ID: 19207263
    [TBL] [Abstract][Full Text] [Related]  

  • 36. FTY720, a synthetic sphingosine 1 phosphate analogue, inhibits development of atherosclerosis in low-density lipoprotein receptor-deficient mice.
    Nofer JR; Bot M; Brodde M; Taylor PJ; Salm P; Brinkmann V; van Berkel T; Assmann G; Biessen EA
    Circulation; 2007 Jan; 115(4):501-8. PubMed ID: 17242282
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The immunomodulator FTY720 is phosphorylated and released from platelets.
    Anada Y; Igarashi Y; Kihara A
    Eur J Pharmacol; 2007 Jul; 568(1-3):106-11. PubMed ID: 17553484
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of thymus in operational tolerance induction in limb allograft transplant model.
    Siemionow M; Izycki D; Ozer K; Ozmen S; Klimczak A
    Transplantation; 2006 Jun; 81(11):1568-76. PubMed ID: 16770246
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The sphingosine 1-phosphate receptor agonist FTY720 potently inhibits regulatory T cell proliferation in vitro and in vivo.
    Wolf AM; Eller K; Zeiser R; Dürr C; Gerlach UV; Sixt M; Markut L; Gastl G; Rosenkranz AR; Wolf D
    J Immunol; 2009 Sep; 183(6):3751-60. PubMed ID: 19692647
    [TBL] [Abstract][Full Text] [Related]  

  • 40. FTY720 induced Bcl-associated and Fas-independent apoptosis in human renal cancer cells in vitro and significantly reduced in vivo tumor growth in mouse xenograft.
    Ubai T; Azuma H; Kotake Y; Inamoto T; Takahara K; Ito Y; Kiyama S; Sakamoto T; Horie S; Muto S; Takahara S; Otsuki Y; Katsuoka Y
    Anticancer Res; 2007; 27(1A):75-88. PubMed ID: 17352219
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.